Medication info
Amlozal Tablet 5/100 mg (Amlodipine Besylate, Losartan Potassium)

Amlozal Tablet 5/100 mg (Amlodipine Besylate, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
Light pink film-coated tablet with a rectangular shape
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 201502659 · Approved 2015.04.30 · Insurance code 650303320

Summary

Main use
Essential hypertension not controlled with monotherapy; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same strengths of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Use of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high-dose diuretics). (See Section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For elderly patients 75 years of age or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of this drug as initial therapy is not recommended.
Child dose
○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Essential hypertension not controlled with monotherapy; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or losartan. It is also effective for initial treatment in stage 2 hypertension patients who require combination therapy to reach target blood pressure. By managing blood pressure stably, it helps prevent complications related to hypertension.

How to take

Adult dose

The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this drug may be considered as follows. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this drug (a combination product containing the same strengths of each active ingredient) for convenience. Before administering this drug as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this drug is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with intravascular volume depletion: Use of this drug is not recommended in a small number of patients with intravascular volume depletion (e.g., patients receiving treatment with high-dose diuretics). (See Section 1, Warnings, in Precautions for Use.) ○ Patients with hepatic impairment: Use of this drug is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Elderly patients: For elderly patients 75 years of age or older, an initial losartan dose of 25 mg once daily is recommended; therefore, use of this drug as initial therapy is not recommended.

Child dose

○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This drug can cause severe harm to the fetus if taken during pregnancy, especially in the 2nd and 3rd trimesters, so it should be discontinued immediately once pregnancy is confirmed. Due to its blood pressure-lowering effects, dizziness may occur; caution is needed when engaging in hazardous activities such as working at heights or driving. This medication should not be used in patients with severely impaired liver function, severe aortic stenosis, or in patients in shock. When starting this medication, patients with reduced blood volume may experience symptoms of hypotension, so their condition should be well managed beforehand. Elderly patients or those with impaired kidney function may require dose adjustment, and those with allergies to the ingredients of this drug should avoid taking it. During use, symptoms such as dizziness, headache, drowsiness, and other side effects may occur due to blood pressure reduction, and rarely, allergic reactions such as skin rashes or breathing difficulties may happen. When taken with other antihypertensive agents, the effect may be enhanced, so it should be administered after consulting a physician. Taking this medication with grapefruit juice may increase the concentration of the drug in the blood and raise the risk of side effects, thus it is advisable to avoid it. This drug is not recommended for breastfeeding women, and its safety has not been established for children under 18 years of age. In the case of overdose, severe hypotension and heart abnormalities may occur, so it is vital to adhere to the prescribed dosages and consult a healthcare professional immediately if any abnormal symptoms arise. This drug must be stored out of reach of children, and transferring it to another container may cause a decrease in quality or increase the risk of accidents.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
Show 145 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • hives
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • increased frequency of urination
  • fatigue
  • edema
  • vasculitis
  • heightened tension
  • sensory loss
  • abnormal sensation
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremors
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • pain
  • weight gain
  • weight loss
  • hypotension
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urination frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinus block
  • atrioventricular block
  • abdominal discomfort
  • epigastric pain
  • diarrhea
  • loose stools
  • skin redness
  • maculopapular rash
  • heaviness
  • warmth sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • back pain
  • muscular cramps
  • myalgia
  • thrombocytopenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decline
  • reduced libido
  • cognitive impairment
  • migraine
  • neuroirritability
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • dermatitis
  • dry skin
  • petechial bleeding
  • erythema
  • photosensitivity
  • rash
  • sweating
  • hives
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • nocturia
  • urethral infection
  • myalgia
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • sinus disorder
  • pharyngitis
  • fatigue
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • abnormal liver function
  • intestinal vascular edema
  • taste disturbance
  • dry cough
  • erythematous skin disease
  • hyperkalemia
  • hyponatremia
  • hypotension
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Light pink film-coated tablet with a rectangular shape

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.